Washington's push to tighten chip export controls lands as China's domestic memory industry, built under earlier restrictions, just produced its most valuable listed company.
Republican Congressman John Moolenaar urged the Trump administration Monday to block advanced logic chips from reaching sanctioned Chinese firms, a push that lands as earlier curbs helped create China's most valuable listed company.
"US firms have had greater access to capital, but financing costs are rising," Chris Miller, author of Chip War and professor at Tufts University, told Bloomberg. "Chinese domestic compute is still more expensive because domestic chips lag on quality, but the gap is closing."
The gap is visible in CXMT Corp, the memory chipmaker that debuted on Shanghai's STAR Market last month and surged 466 percent in a single session, eclipsing Industrial and Commercial Bank of China to become the country's most valuable listed company with a market capitalization above 3.2 trillion yuan ($471.2 billion). CXMT raised $9.8 billion in one of China's biggest IPOs in years.
The stakes extend beyond one company. China's integrated circuit exports reached $216.02 billion in the first seven months of 2026, up 99.5 percent year on year, while Apple, HP and Acer have begun testing or adopting CXMT memory chips — evidence that export controls may have forced Beijing to build a domestic alternative rather than buy American.
From Containment to Catalyst
Moolenaar's call, reported Monday, targets advanced logic chips bound for sanctioned or untrusted Chinese firms, extending restrictions that have already cut off China's access to Nvidia, AMD and their successors. The logic behind the original curbs was direct: no advanced chips meant no path to AI leadership. CXMT's trajectory suggests the opposite.
Beijing cleared the runway fast. CXMT went from filing to trading in under eight months through a preliminary review process reserved for strategically vital companies, a pace that normally takes years. When tech stocks slid in July and threatened to derail the debut, regulators and state funds intervened within days to stabilize sentiment.
The last time Washington tightened chip restrictions this way, in October 2022, Nvidia's China revenue fell sharply while Beijing accelerated domestic substitution programs. This round carries a similar risk: tighter curbs could push more multinationals toward Chinese suppliers. Samsung Electronics and SK Hynix are already evaluating chipmaking equipment from China's Advanced Micro-Fabrication Equipment for use at their Chinese factories, Reuters reported, as the South Korean firms hedge against the risk of tighter US export controls.
The Cost Advantage America Didn't See Coming
Beijing also rewired how it funds the race. China traditionally backed strategic industries with subsidies and state lending. Now it taps the $26 trillion sitting in household savings accounts, the largest pool of private capital in the world. Chinese tech firms borrowed at an average coupon of 1.9 percent this year, more than 300 basis points below US peers paying 5.25 percent, the widest gap since at least 2015.
The IPO pipeline behind CXMT is long. DeepSeek is weighing a listing at a $71 billion valuation. Moonshot AI, whose Kimi K3 model rattled Silicon Valley, is filing in Hong Kong. Z.AI and MiniMax are next. UBS says China's leading AI models cost less than 10 percent of what OpenAI and Anthropic spend to train, and API prices for major Chinese models run below 20 percent of comparable global offerings.
For US chipmakers, the regulatory pressure carries a direct revenue cost. Nvidia, AMD and Intel derive a meaningful share of sales from China, and each tightening round narrows that market while accelerating the domestic competitors Washington sought to contain. If Moolenaar's push becomes policy, the near-term hit to US semiconductor revenue may be smaller than the long-term cost of a China that no longer needs to import.
Washington set out to limit China's options. It may have forced Beijing to build better ones.
This article is for informational purposes only and does not constitute investment advice.